There are key questions to explore over the near-term. Among them:
- The FDA. Was the FDA convinced this local regional treatment can provide a systemic benefit to cancer patients? As the first intralesionally-injected compound that leads to the induction of tumor-specific immunity, does the FDA now understand the systemic benefit component of PV-10?
- Big Pharma. By providing not only anti-tumor immunity, but also inducing tumor-specific immunity, does Big Pharma now understand the systemic potential of PV-10?
Wroclaw University of Economics are CFA Institute Research Challenge Global Final champions. "The CFA Institute Research Challenge is an annual global competition that provides university students with hands-on mentoring and intensive training in financial analysis and professional ethics. Students are tested on their analytic, valuation, report writing and presentation skills, and gain real-world experience as they assume the role of an equity research analyst. More than 3,500 students from over 755 universities in 55 countries participated in the 2012-2013 Research Challenge." To be that close will sting them (and me) for a while, but I think they'll harness this experience and success as they embark on their careers.